Status:
UNKNOWN
Excimer Light and Topical Steroid in Treatment of Alopecia Areata
Lead Sponsor:
Assiut University
Conditions:
Alopecia Areata
Eligibility:
All Genders
16-40 years
Phase:
PHASE4
Brief Summary
Alopecia areata is a polygenic autoimmune disease causing hair loss, particularly during the anagen phase of hair growth This condition has a lifetime risk of about 2.1% of the world population and th...
Detailed Description
Alopecia Areata can have a large impact on patients' quality of life, causing both cosmetic and psychosocial distress. Studies on the impact of hair loss have shown high levels of self-consciousness, ...
Eligibility Criteria
Inclusion
- aged 16-40 years,
- Good general health,
- A clinical diagnosis of multiple Alopecia Areata of the scalp.
- Hair loss \<25 percent of the total scalp.
- No use of drugs or hair care products influencing hair growth in the last 2 months.
Exclusion
- Other causes of hair loss (like endocrine or immunological diseases).
- Skin disease in the treatment area.
- Pregnant or lactating patients.
- Hair transplantation history.
- Photosensitivity history.
- Malignant tumor history.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04793945
Start Date
April 1 2021
End Date
September 30 2022
Last Update
March 11 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.